Reports Q1 revenue $1.76M, consensus $1.75M. “We are driving strong market adoption of LungFit PH as we continue to break down barriers and expand our global distribution network,” said Steve Lisi, chairman and CEO. “This momentum in our business resulted in strong sequential revenue growth of approximately 50%, to $1.8 million compared with $1.2 million for the March 31, 2025 quarter. Looking ahead, we expect the trajectory of our sales to support sustained double-digit sequential revenue growth and reaffirm our FY 2026 revenue guidance of $12 to $16 million.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XAIR:
- Beyond Air (XAIR) Q1 Earnings Cheat Sheet
- Beyond Air’s Growth Potential Bolstered by Strategic Agreements and Financial Positioning
- Beyond Air awarded therapeutic gases agreement with Premier, Inc.
- Beyond Air initiated with a Buy at D. Boral Capital
- Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested
